| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 06/13/2002 | WO2002045525A2 Aged companion pet diet |
| 06/13/2002 | WO2001089533A3 Preparation for stabilizing the protective layer on the epithelium of the cornea or the alveoli |
| 06/13/2002 | WO2001037819A3 Use of indirubine derivatives for making medicines |
| 06/13/2002 | WO2000064957A9 Differentially acting op detoxifying sponges |
| 06/13/2002 | US20020072539 For therapy of tumor necrosis factor(TNF), edema, neurological deficits, stroke and for therapy of pathological conditions caused by TNF-alpha |
| 06/13/2002 | US20020072083 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 06/13/2002 | CA2430412A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/13/2002 | CA2427820A1 Method of producing biospecific molecules by protein trans-splicing |
| 06/12/2002 | EP1213282A1 Substituted imidazolium salts and their use for the inhibition of protein ageing. |
| 06/12/2002 | EP1213025A1 Cosmetic and/or dermopharmaceutical composition containing extracts obtained from the leaves of Argania spinosa |
| 06/12/2002 | EP1212353A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf) |
| 06/12/2002 | EP1212323A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/12/2002 | EP1212087A1 Methods and compositions utilizing rad51 |
| 06/12/2002 | EP1212070A1 Plant extract mixtures and their uses |
| 06/12/2002 | EP1212059A1 Iron chelators and uses thereof |
| 06/12/2002 | CN1353613A Pharmaceutical compositions |
| 06/12/2002 | CN1352896A Process for extracting genistein as anticancer and oncogenic dioxanin resistant substance from fermented soybean |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403788 Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
| 06/11/2002 | US6403618 Administering picolinic acid derivatives to chelate with zinc and iron in proteins; antiangiogenic and antineoplastic agent |
| 06/11/2002 | US6403093 Methods to detect granulocytic ehrlichiosis |
| 06/11/2002 | CA2239705C Quinazoline-4-one ampa antagonists |
| 06/11/2002 | CA2124218C Cytotoxic drug therapy |
| 06/06/2002 | WO2002044187A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 06/06/2002 | WO2002043744A1 Excretion accelerator for accumulative chlorine compound |
| 06/06/2002 | WO2002043664A2 Reducing cellular damage in the human body |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001012168A3 Antiviral pharmaceutical compositions containing iron chelators |
| 06/06/2002 | WO2000065346A9 Diagnosis of human kidney diseases |
| 06/06/2002 | US20020068102 Use of dietary supplement includes juice from fruit of Morinda citrifolia to scavange lipid hydroperoxides and superoxide anion free radicals within the human body |
| 06/06/2002 | US20020068094 Physiologically active exract |
| 06/06/2002 | US20020068083 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 06/06/2002 | CA2430133A1 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 06/05/2002 | EP1210444A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 06/05/2002 | EP1210353A1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 06/05/2002 | EP1210105A1 High density lipoprotein against organ dysfunction following haemorrhagic shock |
| 06/05/2002 | EP1210102A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/05/2002 | EP1210090A2 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 06/05/2002 | EP1210073A1 Sunscreen agent for oral administration |
| 06/05/2002 | EP1209987A1 Composition for preventing iodine deficiency |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399139 Controlling material handling |
| 05/30/2002 | WO2002042336A2 Fgf-affinity chromatography |
| 05/30/2002 | WO2001085149A3 Felbamate derived compounds |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1207878A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 05/29/2002 | EP1207848A1 Purifying and/or regenerating agent |
| 05/29/2002 | EP1061812A4 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 05/29/2002 | CN1350850A Soft capsule of superfine compound pearl powder and its preparing process |
| 05/29/2002 | CN1085674C Safflower total uranidin, its preparation and application |
| 05/28/2002 | US6394812 Vivo induction for enhanced function of isolated hepatocytes |
| 05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 05/23/2002 | WO2002040463A1 Macrocyclic compound |
| 05/23/2002 | WO2002040033A1 Formulation containing phosphate derivatives of electron transfer agents |
| 05/23/2002 | WO2002040003A1 Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 05/23/2002 | US20020061910 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | DE10056400A1 Galenische Formulierung Drug formulation |
| 05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 05/22/2002 | EP1107996B1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 05/22/2002 | CN1085080C Medicine for treating and preventing saturnism and its preparing process |
| 05/21/2002 | US6391899 Stroke therapy; cardiovascular disorders |
| 05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
| 05/16/2002 | WO2002038181A2 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2001089514A3 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent |
| 05/16/2002 | US20020058669 Process for the treatment of organophosphate poisoning |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058058 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 05/16/2002 | CA2428318A1 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
| 05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
| 05/15/2002 | EP1205475A1 Flavonoid compounds for use against oxidative stress and UV radiation |
| 05/15/2002 | EP1102594B1 Use of sodium chloride to reduce the gastrointestinal toxicity of camptothecin derivatives |
| 05/15/2002 | EP1019067A4 Methods of using emu oil and active fractions thereof as an insect repellent |
| 05/15/2002 | CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349409A Metabolic intervention with GLP-1 to improve the function of ischemic anc reperfused tissue |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/14/2002 | US6387902 Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387891 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 05/14/2002 | US6387877 Removal lipopolysaccharides from glycoproteins; antiinflammatory agents |
| 05/10/2002 | WO2002036605A2 Estrone-derivatives having cytoprotective activity |
| 05/10/2002 | WO2002036162A2 Compositions for treatment of ocular neovascularization and neural injury |
| 05/10/2002 | WO2002036098A1 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 05/10/2002 | WO2002016381A3 Composition and method for inhibiting platelet aggregation |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055471 Purification step using a brominated polystyrene resin to adsorb anthocyanins |
| 05/09/2002 | US20020055460 Adminstering a compound that binds to a receptor for the glucagon-like peptide-1 (GLP-1) |
| 05/09/2002 | US20020054922 Cosmetic composition and method |
| 05/09/2002 | US20020054881 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |